Immuno-Oncology 360° 2018, NYC New York, USA 7-9 February 2018

Description:
Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R and D, addressing aspects from all facets of IO including:
Discovery/Preclinical Science
Translational Science
Clinical Development
Business Aspects
Investor Relations
Emerging Technologies
Biomarkers / Diagnostics
Trends in the Field

Lead Advisors Dr Axel Hoos, GSK, and Dr James Gulley, NCI, developed the 4th annual IO360° program to include 45 speakers and over 30 talks. Dr Andrew Baum is the investor relations plenary keynote.

URL:
Website: https://go.evvnt.com/149446-1

Prices:
Pharma and Biotech starting rate: USD 1895,
Standard Industry starting rate: USD 1895,
Academia, Non-Profit and Government starting rate: USD 947.50.

Speakers: James Gulley MD PhD, Axel Hoos MD PhD, Andrew Baum MD, Roy Baynes MD PhD, Ali Behbahani MD MBA, Jeff Bockman PhD, Bruce Booth DPhil, Lisa Butterfield PhD, Dario Campana MD PhD, John D Carroll, Jasmine Ferrer DPhil, Simone Fishburn PhD, Simeon George MD, William Grossman MD PhD, Laura Johnson PhD, Lanny Kirsch MD, Ron Korn MD PhD, Corey Langer MD FACP, Patrick Mayes PhD, Ian McCaffery PhD, Adam Millinger, Naiyer Rizvi MD, Greg Simon JD, Julius Strauss MD, Hiroomi Tada MD PhD, Jonathan Wan, Jeffrey Weber MD PhD, Cissy Young PhD MBA

Time: 8:00 am to 5:00 pm.